Data / Form D filings / Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc.: Form D filings
Vivos Therapeutics, Inc., a biotechnology company in Highlands Ranch, CO, filed 4 Form D notices with the SEC between 2017 and 2020. The latest, on February 20, 2020, reports $50,000 sold of a $18 million offering to 1 investor.
Find out what Vivos Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9137 South Ridgeline Blvd., Suite 135, Highlands Ranch, CO, 80129
- Phone
- (720) 239-7366
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Wyoming
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1716166
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 20, 2020 | New notice | $18,000,000 | $50,000 | $17,950,000 | 1 | Feb 10, 2020 | sec.gov |
| May 16, 2019 | New notice | $5,000,000 | $556,500 | $4,443,500 | 9 | May 1, 2019 | sec.gov |
| Sep 29, 2017 | Amendment | $3,000,000 | $0 | $3,000,000 | 0 | Sep 1, 2017 | sec.gov |
| Sep 28, 2017 | New notice | $300,000,000 | $0 | $300,000,000 | 0 | Sep 1, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert D. Mitchell | Director | |
| Carol D. Coughlin | Director | |
| Cody Dave Teets | Director | |
| Bradford Dave Amman | Executive Officer | |
| Gurdev Dave Singh | Executive Officer, Director | |
| R. Kirk Huntsman | Executive Officer, Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Feb 17, 2020 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vivos Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.